Surabhi Pathak

Surabhi Pathak practices at UK King's Daughters in Ashland, Kentucky.

Surabhi Pathak's NPI, 1285999284, was assigned on July 6, 2012. Surabhi Pathak holds Kentucky license 53501.

Surabhi Pathak's primary practice is UK King's Daughters, at 2201 Lexington Ave, Ashland, KY 41101 in Boyd County. The practice phone is (606) 408-4000.

Surabhi Pathak's primary practice is UK King's Daughters in Ashland, Kentucky. Surabhi Pathak is also affiliated with UK King's Daughters Medical Center. The medical group on file is UK King's Daughters Cardiology. Dmand AI also links Surabhi Pathak to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Surabhi Pathak practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Surabhi Pathak's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Surabhi Pathak's licenses on file in 2 states: Kentucky and New York.

CMS data shows 789 Medicare services from Surabhi Pathak across 9 procedure codes in 2024, for 222 Medicare patients. Medicare paid $46,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 222 Medicare patients who saw Surabhi Pathak in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Surabhi Pathak's median patient age at 67, with 63% women.

In 2024, Surabhi Pathak wrote 1,962 Medicare Part D claims for 295 patients. 84% of them were for generic drugs. CMS names the drug for 1,609 of them, across 49 drugs with 11 or more claims each, at $1,677,815 in total drug cost. In 2023, CMS named 638 claims across 22 drugs.

Surabhi Pathak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Surabhi Pathak as offering telehealth.

Dmand AI links 9 papers to Surabhi Pathak, published from 2011 to 2023. 2021 was the busiest year, with 2. Surabhi Pathak's most frequent co-authors are Mohamad Bassam Sonbol, MD, Tanios S. Bekaii-Saab, MD and Jason Scott Starr, DO.

CMS Open Payments shows 81 general payments to Surabhi Pathak from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $262.